HIV Restriction Factors and Mechanisms of Evasion
- PMID: 22553496
- PMCID: PMC3331687
- DOI: 10.1101/cshperspect.a006940
HIV Restriction Factors and Mechanisms of Evasion
Abstract
Retroviruses have long been a fertile model for discovering host-pathogen interactions and their associated biological principles and processes. These advances have not only informed fundamental concepts of viral replication and pathogenesis but have also provided novel insights into host cell biology. This is illustrated by the recent descriptions of host-encoded restriction factors that can serve as effective inhibitors of retroviral replication. Here, we review our understanding of the three restriction factors that have been widely shown to be potent inhibitors of HIV-1: namely, APOBEC3G, TRIM5α, and tetherin. In each case, we discuss how these unrelated proteins were identified, the mechanisms by which they inhibit replication, the means used by HIV-1 to evade their action, and their potential contributions to viral pathogenesis as well as inter- and intraspecies transmission.
Figures





Similar articles
-
Restriction of retroviral replication by APOBEC3G/F and TRIM5alpha.Trends Microbiol. 2008 Dec;16(12):612-9. doi: 10.1016/j.tim.2008.08.013. Epub 2008 Oct 29. Trends Microbiol. 2008. PMID: 18976920 Free PMC article. Review.
-
Human cellular restriction factors that target HIV-1 replication.BMC Med. 2009 Sep 16;7:48. doi: 10.1186/1741-7015-7-48. BMC Med. 2009. PMID: 19758442 Free PMC article. Review.
-
Harnessing the therapeutic potential of host antiviral restriction factors that target HIV.Expert Rev Anti Infect Ther. 2013 Jan;11(1):1-4. doi: 10.1586/eri.12.146. Expert Rev Anti Infect Ther. 2013. PMID: 23428096 No abstract available.
-
Intracellular defenses against HIV, viral evasion and novel therapeutic approaches.J Formos Med Assoc. 2011 Jun;110(6):350-62. doi: 10.1016/S0929-6646(11)60053-3. J Formos Med Assoc. 2011. PMID: 21741003 Review.
-
Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors.Proc Natl Acad Sci U S A. 2010 Mar 16;107(11):5166-71. doi: 10.1073/pnas.0913650107. Epub 2010 Mar 1. Proc Natl Acad Sci U S A. 2010. PMID: 20194752 Free PMC article.
Cited by
-
Association of APOBEC3G genotypes and CD4 decline in Thai and Cambodian HIV-infected children with moderate immune deficiency.AIDS Res Ther. 2012 Nov 24;9(1):34. doi: 10.1186/1742-6405-9-34. AIDS Res Ther. 2012. PMID: 23181827 Free PMC article.
-
Gene therapy with plasmids encoding IFN-β or IFN-α14 confers long-term resistance to HIV-1 in humanized mice.Oncotarget. 2016 Nov 29;7(48):78412-78420. doi: 10.18632/oncotarget.12512. Oncotarget. 2016. PMID: 27729616 Free PMC article.
-
HIV-1 antiretroviral drug therapy.Cold Spring Harb Perspect Med. 2012 Apr;2(4):a007161. doi: 10.1101/cshperspect.a007161. Cold Spring Harb Perspect Med. 2012. PMID: 22474613 Free PMC article. Review.
-
Redoxal, an inhibitor of de novo pyrimidine biosynthesis, augments APOBEC3G antiviral activity against human immunodeficiency virus type 1.Virology. 2015 Oct;484:276-287. doi: 10.1016/j.virol.2015.06.014. Epub 2015 Jul 1. Virology. 2015. PMID: 26141568 Free PMC article.
-
Guanylate binding protein 5: Impairing virion infectivity by targeting retroviral envelope glycoproteins.Small GTPases. 2017 Jan 2;8(1):31-37. doi: 10.1080/21541248.2016.1189990. Epub 2016 Jun 8. Small GTPases. 2017. PMID: 27275775 Free PMC article.
References
-
- Bergeron JR, Huthoff H, Veselkov DA, Beavil RL, Simpson PJ, Matthews SJ, Malim MH, Sanderson MR 2010. The SOCS-box of HIV-1 Vif interacts with ElonginBC by induced-folding to recruit its Cul5-containing ubiquitin ligase complex. PLoS Pathog 6: e1000925 10.1371/journal.ppat.1000925 - DOI - PMC - PubMed
-
- Best S, Le Tissier P, Towers G, Stoye JP 1996. Positional cloning of the mouse retrovirus restriction gene Fv1. Nature 382: 826–829 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical